Ledger.Open graph →
SEC Form D · filed June 18, 2024

NephroDI Therapeutics, Inc

Offering
$4.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Michael Grissinger · Seattle, WADirectorRachael Hagan · Philadelphia, PAExec · DirectorBibhash M. Mukhopadhyay · Seattle, WADirectorJeff M. Sands, M.D · Philadelphia, PAExecRachael Hagan · Philadelphia, PAExec · DirectorMichael Grissinger · Seattle, WADirectorBibhash M. Mukhopadhyay · Seattle, WADirectorJeff M. Sands, M.D · Philadelphia, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗